MapLight Therapeutics, Inc.

MapLight Therapeutics is a drug development company focused on treating brain and nervous system disorders. The company is testing several experimental medicines, including drugs for schizophrenia, Alzheimer's disease psychosis, autism, Parkinson's disease, and conditions involving hyperactivity and agitation. The company uses a technology platform to identify which brain circuits are involved in these diseases and then designs drugs to target those circuits. MapLight was incorporated in 2018 and is based in Redwood City, California.